Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Assets [Abstract]
Loans held for sale, at fair value	$ 4,456	$ 11,593
Loans held for investment, at fair value	5,633	83,143
Cash and cash equivalents	8,713	10,727
Restricted cash	0	2,047
Other assets	6,737	10,137
Total assets	25,539	117,647
Liabilities
Accrued expenses and other liabilities	6,270	10,349
Lease liabilities	900	1,323
Credit facility	0	51,653
Total liabilities	7,170	63,325
Commitment and contingencies (Note 6)	0	0
Redeemable preferred stock:
Preferred stock, $0.01 par value, 250,000 shares authorized as of December 31, 2023 and 2022. 144,212 shares issued and outstanding and $144,212 redemption value as of December 31, 2023 and 2022.	144,212	144,212
Stockholders' deficit:
Common stock, $0.01 par value, 5,000,000 authorized shares; 4,684,485 and 2,554,512 shares issued and outstanding, respectively, as of December 31, 2023 and 3,432,294 and 1,783,862 shares issued and outstanding, respectively, as of December 31, 2022.	46	34
Additional paid-in capital	149,160	149,010
Retained earnings	8,970	41,516
Accumulated other comprehensive income	14	20
Treasury stock, at cost, 2,129,973 shares as of December 31, 2023 and 1,648,432 shares as of December 31, 2022.	(284,033)	(280,470)
Total stockholders' deficit	(125,843)	(89,890)
Total liabilities and deficit	$ 25,539	$ 117,647